Denosumab combined with immunotherapy, radiotherapy, and granulocyte-macrophage colony-stimulating factor for the treatment of metastatic nasopharyngeal carcinoma: A case report
Denosumab combined with PRaG therapy could be a new therapeutic approach for the second-line treatment in patients with bone metastases.
Authors
- Tom Wei‐Wu Chen (ORCID: https://orcid.org/0000-0003-4112-4029)
- Liyuan Zhang (ORCID: https://orcid.org/0000-0001-9080-355X)
- Yue-Hong Kong
Institutions
- Soochow University (CN)
- Second Affiliated Hospital of Soochow University (CN)
Publication Details
- Journal
- World Journal of Clinical Oncology
- Published
- 2024-12-11
- DOI
- https://doi.org/10.5306/wjco.v16.i2.95642
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00